Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 1998, p. 436-439, Vol. 42, No. 2
Bristol Centre for Antimicrobial Research and
Evaluation,
Received 21 April 1997/Returned for modification 27 August
1997/Accepted 25 November 1997
The Aeromonas veronii bv. sobria metallo- The functional group 3 While all metallo- A metallo- A. veronii bv. sobria 163a is a clinical isolate obtained
from Hammersmith Hospital, London, United Kingdom. Escherichia
coli DH5 Induction of bacterial strains with cefoxitin and imipenem and
For the preparation of DNA probes, large quantities of plasmid pSA20R
were prepared and cut with EcoRI to release the cloned A. hydrophila AE036 insert. The DNA fragments were separated
by gel electrophoresis, and the fragment carrying cphA (2.0 kb) was recovered, purified by phenol-chloroform extraction, and
precipitated as previously described (11). The E. coli recombinants to be blotted were spot inoculated onto nutrient
agar, and the plate was incubated at 30°C for 4 h. E. coli(pAS20R) and E. coli(pSU18) were used as positive
and negative controls, respectively. The colony blotting and subsequent
DNA hybridization were carried out under conditions previously
described (11).
DNA sequence determination was performed with the Du Pont Genesis
2000 automated sequencer. Sequences were determined on both strands with a custom primer walking strategy. Compilation of resulting
DNA sequences, database searches, and sequence alignments were
performed with the LASERGENE suite of programs (DNASTAR, West Ealing,
London, United Kingdom).
ImiS was purified as previously described (24). The enzyme
was digested with either trypsin or endoproteinase Glu-C. In both
cases, digestion was carried out for 16 h at 37°C at an
ImiS-to-restriction enzyme ratio of 200:1 (6).
Analysis of endoproteinase Glu-C peptides was undertaken only
when sequence information could not be obtained from the
trypsin-peptide mixture. Aliquots of the peptide mixture were
separated by reversed-phase high-pressure liquid chromatography
(Hewlett-Packard 1090) with an Aquapor RP-300 column (200 by 2.1 mm)
eluting at a flow rate of 200 µl ml The 2.0-kb insert from pAS20R was used as a probe for hybridization
with various digests of A. veronii bv. sobria 163a
chromosomal DNA to identify a restriction enzyme combination suitable
for cloning of the imiS gene. The most suitable was
EcoRI and BamHI; the A. hydrophila
cphA 2.0-kb insert hybridized to a 5.5-kb 163a chromosomal
fragment. Both pSU18 and chromosomal DNAs were cut with
EcoRI and BamHI. The cut chromosomal DNA was
fractionated on a 0.7% agarose gel, and DNA fragments of 3.5 to 7.5 kb
were excised and purified. The selected fraction was ligated into pSU18 and subsequently used to transform E. coli DH5 When E. coli strains carrying the clones were used to check
the MICs of various One clone, pUB5826, was chosen for sequencing. The open reading frame
containing imiS extends for 762 nucleotides and encodes a
preprotein of 254 amino acids (Fig. 1).
Upstream of the imiS ORF lie the ribosome-binding site, a
putative The results of the tryptic and Glu-C digests were confirmed by Edman
sequencing. The complete amino acid sequence of ImiS was derived from a
combination of peptide sequence data and peptide molecular mass
determination. The molecular mass of the protein determined by liquid
chromatography-mass spectrometry of incompletely digested protein was
25,247 Da. This value agrees with the theoretical molecular mass of the
protein (25,248 Da). The predicted amino acid sequence shows a perfect
match with the protein sequence as determined by Edman sequencing and
liquid chromatography-electrospray mass spectrophotometry. The protein
sequence confirms the site of the peptide cleavage, between two
alanines at positions 27 and 28, and is identical to that for CphA
(13).
The predicted pI of the secreted gene product is 8.1, similar to the
8.6 reported for CphA (13) but significantly different from
that reported for the AsbM1 enzyme (27). The amino acid sequence of ImiS was compared to those of other group 3
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Nucleotide and Amino Acid Sequences of the Metallo-
-Lactamase,
ImiS, from Aeromonas veronii bv. sobria
![]()
ABSTRACT
Top
Abstract
Text
References
-lactamase
gene, imiS, was cloned. The imiS open reading
frame extends for 762 bp and encodes a protein of 254 amino acids with
a secreted modified protein of 227 amino acids and a predicted pI of
8.1. To confirm the predicted sequence, purified ImiS was digested and
the resulting peptides were identified, yielding an identical sequence
for ImiS, with 98% identity to CphA. Both possessed the putative
active-site sequence Asn-Tyr-His-Thr-Asp at positions 88 to 92, which
is unique to the Aeromonas metallo-
-lactamases.
![]()
TEXT
Top
Abstract
Text
References
-lactamases (2) have assumed increasing clinical
significance due to their ability to hydrolyze carbapenems such as
imipenem and meropenem, which, apart from a few exceptions, are poorly
hydrolyzed by serine
-lactamases. These enzymes are also resistant
to all commercially available serine
-lactamase inhibitors.
Plasmid-mediated metallo-
-lactamases have now been identified in key
pathogens such as Klebsiella pneumoniae, Serratia
marcescens, Pseudomonas aeruginosa, and
Bacteroides fragilis (1, 10, 25, 26).
Furthermore, the metallo-
-lactamase from S. marcescens,
IMP1, has been mobilized on an integron-like gene, intI3,
and has spread to P. putida, K. pneumoniae, and
Alcaligenes spp. (19). These enzymes have also
been identified and characterized from emerging pathogens such as
Aeromonas spp., Stenotrophomonas maltophilia, and Burkholderia cepacia and have been the
subject of recent reviews (14, 15).
-lactamases possess the ability to hydrolyze
carbapenems, their abilities to hydrolyze other
-lactams, such as
penicillins and cephalosporins, vary from enzyme to enzyme. Whereas
most metallo-
-lactamases have a broad spectrum of activity, enzymes
isolated from Aeromonas spp. can readily hydrolyze only carbapenems (17). The sequence of the gene encoding the
Aeromonas hydrophila enzyme CphA was determined by Massidda
et al. (13) and shows significant difference from those of
the metallo-
-lactamases of Bacillus cereus (9)
and B. fragilis (20), including conserved amino
acids thought to be involved with zinc ion binding (3, 4).
Recently, a second A. hydrophila metallo-
-lactamase gene, cphA2, has been sequenced which, not surprisingly, shows
strong homology to cphA (15). Hybridization
studies using the cphA gene probe illustrated that homologs
of the A. hydrophila gene are found in A. veronii, A. caviae, A. jandaei, and other
strains of A. hydrophila, illustrating the widespread
occurrence of this gene in Aeromonas spp. (16).
-lactamase from A. veronii bv. sobria, ImiS,
has been purified and characterized and shown to have a substrate profile very similar to those of both the CphA and A. jandei
AsbM1
-lactamases (5, 24, 27). In addition, the first 40 N-terminal amino acids of ImiS were found to be identical to those of
the CphA enzyme. Interestingly, the A. jandei AsbM1 enzyme
also has had its N-terminal sequence determined and shows only 26%
similarity to CphA over the first 27 amino acids (27). The
purpose of this work was to determine the sequences of both the
A. veronii bv. sobria metallo-
-lactamase gene,
imiS, and its purified product and to compare these
specifically with those of the homologous system in A. hydrophila.
(7) was used as the host strain for
transformation of the A. veronii bv. sobria gene banks.
pSU18 was used as the cloning vector and has been previously described
(12). The A. hydrophila metallo-
-lactamase
gene, cphA, carried on plasmid pAS20R, was a gift from
G. M. Rossolini and has been previously described (13).
All of the media and compounds used have been previously described
(23).
-lactamase assays were carried out as previously described (22). Imipenem hydrolysis was assayed at 298 nm. One unit of
-lactamase activity is defined as the amount of enzyme required to
hydrolyze 1 nmol of substrate/min/mg of protein in the linear phase of
the reaction at 37°C.
1 with a 1%/min
linear increase in acetonitrile (eluent system, water-trifluoroacetic
acid-acetonitrile). Detection was by UV at 214 nm. A 50-µl volume of
digested ImiS was injected per run, and the eluent was split such
that individual peptides could be collected for off-line Edman
N-terminal amino acid sequencing (ABI477A Pulse liquid sequencer)
and also for direct peptide molecular weight determination. Individual
peptides were confirmed by a combination of Edman sequencing
(8) and mass spectroscopy.
to
chloramphenicol resistance. Colonies containing recombinant molecules
were blotted and probed with the cphA probe. Four positive
signals were found after screening of approximately 4,000 transformants, and the recombinant plasmids were designated pUB5826 to
pUB5829. On digestion with EcoRI and BamHI, each
recombinant gave an insert of 5.5 kb plus the cloning vector. The
restricted recombinants were run on an agarose gel, blotted, and probed
with labelled cphA to confirm the identities of the inserts.
All were positive when probed.
-lactams by using standard inocula, they showed
no increase in resistance over that of the host, E. coli DH5
. However, when a larger inoculum (108 bacteria) was
used, the MIC of imipenem increased 8- to 16-fold to a value similar to
that of E. coli(pAS20R) (13). Cell lysates of
E. coli(pUB5826 to pUB5829) were analyzed for
-lactamase production, both with and without induction with
cefoxitin and imipenem. The
-lactamase activities of all of the cell
extracts of strains carrying the imiS clones were very
similar to the activity displayed by E. coli(pAS20R). The
A. veronii bv. sobria metallo-
-lactamase gene was
noninducible when expressed in an E. coli background.
10 promoter box (TATTTT), and a putative
35 promoter box
(TTCACA). However, the spacing between the two components of the
promoter is far from ideal. Immediately downstream of the termination
codon are inverted repeat sequences
(GCTGCCGCGGCGGCAGC) representing a
possible terminator for transcription of the imiS gene. The
imiS ORF sequence shows 94% identity to cphA.
The codon preference of imiS strongly favors cytidine (C)
and guanosine (G) over uridine (U) and adenosine (A) in the third
position. Codon preferences were as follows: NNA, 4.3%; NNU, 10.2%;
NNC, 31.2%; NNG, 54.3%. These preferences reflect the high G+C
content throughout the ORF (62%), similar to the G+C content of other
-lactamase genes analyzed from the same strain of A. veronii bv. sobria (23). Interestingly, the sequence
immediately downstream of imiS shares no homology at all
with the downstream sequence of cphA, including the inverted repeat sequences that may represent a terminator for the transcription of the imiS gene.

View larger version (66K):
[in a new window]
FIG. 1.
Nucleotide sequence of the imiS ORF and
flanking regions. Putative sequences involved in transcription control
and the putative ribosome-binding site (RBS) are underlined. The
deduced amino acid sequence is also shown.
-lactamases. ImiS showed a very high level of identity to CphA (98%), differing at
only seven amino acids (88I, 128E, 138L, 143L, 159Q, 201V, and 225S)
(Fig. 2). Given that cphA has
been shown to hybridize strongly to chromosomal DNAs from several
Aeromonas spp. that produce metallo-
-lactamase
(16), it is likely that the relevant genes in these strains
will show high homologies, a conclusion supported by our findings.
Interestingly, the N-terminal protein sequence of the
metallo-
-lactamase AsbM1 from A. jandei AER14M shows only
26% similarity to both ImiS and CphA over the first 27 amino acids
(27). If this low level of similarity is maintained throughout the AsbM1 protein, it would indicate a major divergence of
the metallo-
-lactamases found in Aeromonas spp.

View larger version (74K):
[in a new window]
FIG. 2.
Alignment of ImiS with other class B
-lactamases
(9, 10, 13, 20, 21). A consensus was noted when five of the
six sequences shared the same amino acid residue. An asterisk denotes
conserved residues similar in function. Sequences in bold are those
thought to be involved in the binding of one of the Zn(II) ions
(3, 4). Bce, B. cereus; Bfr, B. fragilis; Sma, S. marcescens; Ahy, A. hydrophila; Asb, A. veronii bv. sobria; Stm, S. maltophilia.
Both Aeromonas metalloenzymes CphA and ImiS and a third
enzyme from A. hydrophila, encoded by cphA2, show
an Asn-Tyr-His-Thr-Asp sequence at residues 88 to 92, confirming that
the Aeromonas metallo-
-lactamases possess a significantly
different residue, namely, Asn88, in place of a histidine thought to be
involved in zinc coordination and the formation of the active site of
these enzymes. In contrast to other metallo-
-lactamases, the kinetic
profiles of both the A. hydrophila CphA and A. veronii bv. sobria ImiS metallo-
-lactamases demonstrate that
while they can readily hydrolyze carbapenems, they have poor activity
against most other
-lactams (18, 24). The
metallo-
-lactamases of B. cereus, B. fragilis, and S. maltophilia possess the amino acid
motif His-X-His-X-Asp close to the start of the proteins (9, 20,
21). This motif, among other residues, is thought to be
responsible for coordinating the two zinc ions found in the active site
of the other group 3 enzymes (3, 4). The
Aeromonas metallo-
-lactamases CphA, CphA2, and ImiS have the related sequence Asn-Tyr-His-Thr-Asp at the equivalent position. The amino acid residues thought to be needed to bind the second zinc
ion in the enzymes from B. cereus and B. fragilis, namely, Asp90, Cys168, and His210 (4), are
all conserved in the Aeromonas group 3 enzymes. Thus, the
possibility arises that CphA, CphA2, and ImiS may complex just a single
zinc ion and that this consequently results in the narrow hydrolytic
spectra displayed by these enzymes. The structure of ImiS is currently
being determined to resolve, among other points, this particular
question.
Nucleotide sequence accession number. The nucleotide sequence of imiS has been assigned EMBL accession no. Y01415.
| |
ACKNOWLEDGMENTS |
|---|
This work was funded by the Wellcome Trust (grant 038025/2/93/2/1.5).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Bristol Centre for Antimicrobial Research and Evaluation, Department of Microbiology and Pathology, School of Medical Sciences, University Walk, University of Bristol, Bristol BS8 1TD, United Kingdom. Phone: 0117 9282567. Fax: 0117 9287896. E-mail: T.R.WALSH{at}BRISTOL.AC.UK.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bandoh, K., K. Watanabe, Y. Muto, Y. Tanaka, N. Kato, and K. Ueno. 1992. Conjugal transfer of imipenem resistance in Bacterodies fragilis. J. Antibiot. 45:542-547[Medline]. |
| 2. |
Bush, K.,
G. A. Jacoby, and A. A. Medeiros.
1995.
A functional classification scheme for -lactamases and its correlation with molecular structures.
Antimicrob. Agents Chemother.
39:1211-1233[Medline].
|
| 3. |
Concha, N. O.,
B. A. Rasmussen,
K. Bush, and O. Hertzberg.
1996.
Crystal structure of the wide spectrum binuclear zinc -lactamase from Bacteroides fragilis.
Structure
4:823-836[Medline].
|
| 4. |
Crowder, M. W.,
Z. Wang,
S. L. Franklin,
E. P. Zovinka, and S. J. Benkovic.
1996.
Characterization of the metal-binding sites of the -lactamase from Bacteroides fragilis.
Biochemistry
35:12126-12132[Medline].
|
| 5. |
Felici, A.,
G. Amicosante,
A. Oratore,
R. Strom,
P. Ledent,
B. Joris,
L. Fanuel, and J.-M. Frere.
1993.
An overview of the kinetic parameters of class B -lactamases.
Biochem. J.
291:151-155.
|
| 6. |
Flannery, A. V.,
R. J. Beynon, and J. S. Bond.
1989.
Proteolysis of proteins for sequence analysis and peptide mapping, p. 150.
In
R. J. Beynon, and J. S. Bond (ed.), Proteolytic enzymes a practical approach. IRL Press, Oxford, England.
|
| 7. | Hanahan, D. 1983. Studies on the transformation of Escherichia coli with plasmids. J. Mol. Biol. 45:37-67. |
| 8. |
Hewick, R. M.,
M. W. Hunkapiller,
L. E. Hood, and W. J. Dreyer.
1981.
A gas-liquid solid phase peptide sequenator.
J. Biol. Chem.
256:7990-7997 |
| 9. |
Hussain, M.,
A. Carlino,
M. J. Madonna, and J. O. Lampen.
1985.
Cloning and sequencing of the metallothioprotein -lactamase II gene of Bacillus cereus 569/H in Escherichia coli.
J. Bacteriol.
164:223-229 |
| 10. |
Ito, H.,
Y. Arakawa,
S. Ohsuka,
R. Wacharotayankun,
N. Kato, and M. Ohta.
1995.
Plasmid-mediated dissemination of the metallo- -lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.
Antimicrob. Agents Chemother.
39:824-829[Abstract].
|
| 11. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 12. | Martinez, E., B. Bartolome, and F. de la Cruz. 1988. pACYC184-derived cloning vectors containing the multiple cloning site and lacZ-alpha reporter gene of pUC8/9 and pUC18/19 plasmids. Gene 68:159-162[Medline]. |
| 13. |
Massidda, O.,
G. M. Rossolini, and G. Satta.
1991.
The Aeromonas hydrophila cphA gene: molecular heterogeneity among class B metallo- -lactamases.
J. Bacteriol.
173:4611-4617 |
| 14. |
Payne, D. J.
1993.
Metallo- -lactamases.
J. Med. Microbiol.
39:93-99 |
| 15. |
Rasmussen, B. A., and K. Bush.
1997.
Carbapenem-hydrolyzing -lactamases.
Antimicrob. Agents Chemother.
41:223-232[Medline].
|
| 16. |
Rossolini, G. M.,
A. Zanchi,
A. Chiesurin,
G. Amicosante,
G. Satta, and P. Guglielmetti.
1995.
Distribution of cphA or related carbapenemase-encoding genes and production of carbapenemase activity in members of the genus Aeromonas.
Antimicrob. Agents Chemother.
39:346-349 |
| 17. |
Rossolini, G. M.,
T. R. Walsh, and G. Amicosante.
1996.
The Aeromonas metallo- -lactamases: genetics, enzymology, and contribution to drug resistance.
Microb. Drug Resist.
2:245-252.
[Medline] |
| 18. |
Segatore, B.,
O. Massidda,
G. Satta,
D. Setacci, and G. Aminocosante.
1993.
High specificity of cphA-encoded metallo- -lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to -lactam resistance.
Antimicrob. Agents Chemother.
37:1324-1328 |
| 19. |
Senda, K.,
Y. Arakawa,
K. Nakashima,
H. Ito,
S. Ichiyama,
K. Shimokata,
N. Kato, and M. Ohta.
1996.
Multifocal outbreaks of metallo- -lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum -lactams, including carbapenems.
Antimicrob. Agents Chemother.
40:349-353[Abstract].
|
| 20. |
Thompson, J. S., and M. H. Malamy.
1990.
Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus -lactamase II.
J. Bacteriol.
172:2584-2593 |
| 21. |
Walsh, T. R.,
L. Hall,
S. J. Assinder,
W. W. Nichols,
S. J. Cartwright,
A. P. MacGowan, and P. M. Bennett.
1994.
Sequence analysis of the L1 metallo- -lactamase from Xanthomonas maltophilia.
Biochim. Biophys. Acta
1218:199-201[Medline].
|
| 22. |
Walsh, T. R.,
D. J. Payne,
A. P. MacGowan, and P. M. Bennett.
1995.
A clinical isolate of Aeromonas sobria with three chromosomal mediated inducible -lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity.
J. Antimicrob. Chemother.
35:271-279 |
| 23. |
Walsh, T. R.,
L. Hall,
A. P. MacGowan, and P. M. Bennett.
1995.
Sequence analysis of two chromosomally mediated inducible -lactamases from a clinical isolate of Aeromonas sobria, strain 163a, one a group 2d penicillinase, the other a group 1 AmpC cephalosporinase.
J. Antimicrob. Chemother.
36:41-47 |
| 24. |
Walsh, T. R.,
D. C. Emery,
S. J. Gamblin,
A. P. MacGowan, and P. M. Bennett.
1996.
Enzyme kinetics and biochemical analysis of ImiS, a metallo- -lactamase from Aeromonas sobria.
J. Antimicrob. Chemother.
37:423-431 |
| 25. |
Watanabe, M.,
S. Iyobe,
M. Inoue, and S. Mitsuhashi.
1991.
Transferable imipenem resistance in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
35:147-151 |
| 26. |
Yamaguchi, H.,
M. Nukaga, and T. Sawai.
1994.
Sequence of the Klebsiella pneumoniae RDK4 metallo- -lactamase. Accession no. D29636.
EMBO Database.
|
| 27. |
Yang, Y., and K. Bush.
1996.
Biochemical characterisation of the carbapenem-hydrolysing -lactamase AsbM1 from Aeromonas sobria AER14M: a member of a novel subgroup of metallo- -lactamases.
FEMS Microbiol. Lett.
137:193-200[Medline].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»